These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7122989)

  • 21. Induction of liver microsomal cytochrome P-450 and associated monooxygenases by octachlorostyrene in the rat.
    Holme JA; Dybing E
    Acta Pharmacol Toxicol (Copenh); 1982 Jan; 50(1):41-9. PubMed ID: 7064718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of doxylamine succinate on thyroid hormone balance and enzyme induction in mice.
    Bookstaff RC; Murphy VA; Skare JA; Minnema D; Sanzgiri U; Parkinson A
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):584-94. PubMed ID: 8975784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleomycin inhibits hepatic mixed function oxidation.
    Montgomery MR; Furry J; Fernandez S
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):287-93. PubMed ID: 6175013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, a potent phenobarbital-like inducer of microsomal monooxygenase activity.
    Poland A; Mak I; Glover E; Boatman RJ; Ebetino FH; Kende AS
    Mol Pharmacol; 1980 Nov; 18(3):571-80. PubMed ID: 7464820
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of sulfamethazine on mixed function oxidase in chickens.
    Kodam KM; Govindwar SP
    Vet Hum Toxicol; 1995 Aug; 37(4):340-2. PubMed ID: 8540224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of hepatic cytochrome P-450 by phenobarbital in semi-aquatic frog (Rana pipiens).
    Khan MA; Qadri SY; Tomar S; Fish D; Gururajan L; Poria MS
    Biochem Biophys Res Commun; 1998 Mar; 244(3):737-44. PubMed ID: 9535735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of benzpyrene and allylestrenol in fetal or neonatal periods of life: does it make difference in the microsomal activity?
    Karabélyos C; Szeberényi S; Csaba G
    Acta Physiol Hung; 1994; 82(4):331-7. PubMed ID: 7785443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of cyclic nucleotide- and calcium-regulated pathways in phenobarbital-induced cytochrome P-450 3A expression in mouse primary hepatocytes.
    Galisteo M; Marc N; Fautrel A; Guillouzo A; Corcos L; Lagadic-Gossmann D
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1270-7. PubMed ID: 10454503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of dantrolene with the hepatic mixed function oxidase system.
    Roy S; Francis FT; Born CK; Hamrick ME
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):507-20. PubMed ID: 7384640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of N1,N3-diallyluracil and N1,N3-diallylthymine on hepatic drug-metabolizing enzymes of mice.
    Tateoka Y; Kimura T; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):135-43. PubMed ID: 2748995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of aflatoxin B1 on the hepatic microsomal mixed function oxidase system during phenobarbital and benzo(a)pyrene treatment in chickens.
    Govindwar SP; Adav SS
    Vet Hum Toxicol; 1999 Aug; 41(4):210-2. PubMed ID: 10434373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cytochrome P4501A1 in teleosts: sustained induction of CYP1A1 mRNA, protein, and catalytic activity by 2,3,7,8-tetrachlorodibenzofuran in the marine fish Stenotomus chrysops.
    Hahn ME; Stegeman JJ
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):187-98. PubMed ID: 8048062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nutritional obesity on the induction of CYP2B enzymes following phenobarbital treatment.
    Zannikos PN; Bandyopadhyay AM; Robertson LW; Blouin RA
    Drug Metab Dispos; 1993; 21(5):782-7. PubMed ID: 7902236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cimetidine: a specific inhibitor of hepatic aryl hydrocarbon hydroxylase (AHH) in the rat.
    Drew R; Rowell J; Grygiel JJ
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):81-93. PubMed ID: 7268211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatic enzyme induction by 3-methylcholanthrene-type PCB and development of its toxicity].
    Yoshihara S; Nagata K; Wada I; Koga N; Yoshimura H
    Fukuoka Igaku Zasshi; 1983 May; 74(5):209-16. PubMed ID: 6411562
    [No Abstract]   [Full Text] [Related]  

  • 36. Phenobarbital liver microsomal induction in MHV-3 viral hepatitis of the mouse.
    Budillon G; Carrella M; Coltorti M
    Experientia; 1972 Sep; 28(9):1011-2. PubMed ID: 4146656
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytochrome P450 induction by phenobarbital (PB) is inhibited by 12-O-tetradecanoylphorbol-13-acetate (TPA): evidence that protein kinase C regulates induction.
    Steele DF; Virgo BB
    Biochem Biophys Res Commun; 1988 Jun; 153(2):728-33. PubMed ID: 3382400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibition and potentiation of procarbazine on hepatic mixed-function oxidases in phenobarbital tolerant and nontolerant mice.
    Onoda K; Ho IK
    Drug Chem Toxicol; 1980; 3(2):185-200. PubMed ID: 7227217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of arsenite on hepatic mixed-function oxidase activity in rats.
    Albores A; Cebrian ME; Connelly JC; Bach PH; Bridges JW
    Xenobiotica; 1992 May; 22(5):591-7. PubMed ID: 1413874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery from dispositional and pharmacodynamic tolerance after chronic pentobarbital treatment.
    Okamoto M; Rao SN; Reyes J; Rifkind AB
    J Pharmacol Exp Ther; 1985 Oct; 235(1):26-31. PubMed ID: 4045724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.